drugset / Trial / NCT02652585

Validation of a Test System for Development of Medications for Alcoholism

NCT02652585

Phase 3 Completed 46 enrolled Technical University Dresden
RandomizedParallel-groupTriple-blindBasic science

Summary

Using theTEMA (test system for development of medications for alcoholism) it can be shown, that naltrexone administration reduces the willingness to perform work for alcohol infusion in a laboratory experiment.

Timeline

Start
2016-02
Primary completion
2017-08-25
Completion
2017-09-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Naltrexone Small molecule 50 mg Oral

Indications